Vivos Therapeutics, Inc. (NASDAQ: VVOS) opened a new affiliate sleep testing and treatment center in Auburn Hills, Michigan on December 16, 2025. The facility, built in partnership with MISleep Solutions, replaces the company’s legacy dentist‑centric model with a capital‑efficient alliance to a medical sleep practice.
The Auburn Hills location will provide Vivos’ FDA‑cleared Vivos Method oral appliances and diagnostic services to patients newly diagnosed with obstructive sleep apnea. By embedding its products in a medical sleep practice, Vivos gains direct access to a high‑volume patient pool, captures higher‑margin service revenue, and remains compliant with corporate practice of medicine rules.
Vivos’ Q3 2025 results illustrate the impact of this strategic shift. Revenue rose 76% YoY to $6.8 million, driven largely by the acquisition of the Sleep Center of Nevada and the new affiliate model. Gross margin fell 2 percentage points to 58% from 60% in Q3 2024, a compression attributed to pricing discounts, a shift in product/service mix, and the transition to the new model. Net loss widened to $5.4 million, reflecting ongoing investments in expansion and the higher operating costs of the new center.
Chairman and CEO Kirk Huntsman said the partnership “brings an exciting and highly differentiated set of diagnostic and treatment options to patients, creating additional revenue streams and higher‑margin services for Vivos.” He added that the new model is a key step toward achieving cash‑flow positive operations in 2025.
While no immediate market reaction has been reported, the opening is part of a broader strategy to accelerate revenue growth and reduce capital intensity. The new center is expected to contribute to the company’s revenue trajectory and support its goal of moving toward cash‑flow positive operations, but specific financial projections for the Auburn Hills location have not yet been disclosed.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.